Theramyt Novobiologics Pvt.

PharmaceuticalsSeries ABangalore, Indiatheramyt.com

Latest round

Series A

Last raised

Sep 2013

Total raised

$4.3M

Investors

4

About Theramyt Novobiologics Pvt.

Theramyt Novobiologics is based in India and operates as a biobetters, biosimilars and NBEs developer which improve patient access to cost-effective, regulatory-compliant therapies.

Who invested in Theramyt Novobiologics Pvt.

4 investors across 1 round

See all investors in Theramyt Novobiologics Pvt.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Sep 20, 2013

    Amount

    $4.3M

    Investors

    Locked

Questions about Theramyt Novobiologics Pvt.

Who invested in Theramyt Novobiologics Pvt.?

Theramyt Novobiologics Pvt. has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Theramyt Novobiologics Pvt. raised?

Theramyt Novobiologics Pvt. has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Theramyt Novobiologics Pvt. last raise money?

Theramyt Novobiologics Pvt.'s most recent round on record is a Series A, in Sep 2013.

What does Theramyt Novobiologics Pvt. do?

Theramyt Novobiologics is based in India and operates as a biobetters, biosimilars and NBEs developer which improve patient access to cost-effective, regulatory-compliant therapies.

Where is Theramyt Novobiologics Pvt. headquartered?

Theramyt Novobiologics Pvt. is headquartered in Bangalore, India.

Which VCs invest in companies like Theramyt Novobiologics Pvt.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Theramyt Novobiologics Pvt.'s stage. Their profiles are linked below.

Raising like Theramyt Novobiologics Pvt.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.